Key statistics
As of last trade Pharming Group NV (PHG:FRA) traded at 13.20, -24.14% below its 52-week high of 17.40, set on Jan 26, 2026.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 13.20 |
|---|---|
| High | 13.20 |
| Low | 13.20 |
| Bid | 13.40 |
| Offer | 14.40 |
| Previous close | 13.40 |
| Average volume | 0.00 |
|---|---|
| Shares outstanding | -- |
| Free float | -- |
| P/E (TTM) | -- |
| Market cap | -- |
| EPS (TTM) | -- |
Data delayed at least 15 minutes, as of Mar 02 2026 07:55 GMT.
More ▼
- Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12
- Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference
- Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
- Pharming Group receives Complete Response Letter from U.S. FDA for sNDA for Joenja® (leniolisib) in children aged 4 to 11 years with APDS
- Original-Research: Pharming Group NV (von First Berlin Equity Research GmbH): Buy
- Pharming Group reports preliminary 2025 revenues and announces Investor Day
- Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit
- Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow
- Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London
- Pharming Group to report third quarter 2025 financial results and provide business update on November 6
More ▼
